Evidence map›Paper›PMID 39283962›Full record

ArticleThe Journal of clinical endocrinology and metabolism2025

Serum Phosphate in the General Population: A Need for Sex-Specific Reference Intervals.

Ariadne Bosman, Natalia Campos-Obando, Christian Ramakers, M Carola Zillikens

Abstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ariadne BosmanDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands.ORCID 0000-0002-7466-1472
Natalia Campos-ObandoDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands.
Christian RamakersDepartment of Clinical Chemistry, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands.
M Carola ZillikensDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, the Netherlands.ORCID 0000-0001-9186-3423

Funding

Health∼Holland LSHM18029
6 · The paper itself

Abstract

contextPhosphate is important for several metabolic functions and essential for bone mineralization. Sex differences exist in the relation between serum phosphate and certain diseases. The reference interval for phosphate is age-adjusted in infants, but most institutions use the same intervals for adult men and women despite increasing evidence for age and sex differences.

objectiveWe aimed to study these differences in 2 large population-based cohorts to evaluate whether current reference intervals are adequate.

methodsA total of 8837 participants from 3 cohorts of the Rotterdam Study (RS) and 422 443 participants from the UK Biobank (UKBB), aged 40 and older and without chronic kidney disease, were analyzed for sex differences in serum phosphate using standard reference values (0.8-1.45 mmol or 2.5-4.5 mg/dL). Analyses were further stratified in women by menopausal status.

resultsWomen had higher serum phosphate concentrations and a higher population range compared to men in all cohorts. Hypophosphatemia was more prevalent in men and hyperphosphatemia was more prevalent in women. Sex differences were present in all age categories. Perimenopausal women had higher serum phosphate concentrations than men of the same age, but lower than postmenopausal women of the same age.

conclusionThis study in 2 population-based cohorts showed that women have higher serum phosphate concentrations than men and that women show a marked increase in serum phosphate during menopause. Moreover, the population range for serum phosphate was higher in women than in men. These findings indicate a need for sex-specific reference intervals for serum phosphate in adults older than 45 years.

Indexed as

PhosphatesAdultAgedAged, 80 and overCohort StudiesFemaleHumansHyperphosphatemiaHypophosphatemiaMaleMenopauseMiddle AgedNetherlandsReference ValuesSex CharacteristicsSex FactorsPhosphatesepidemiologygenderhyperphosphatemiahypophosphatemiaphosphate

Identifiers

PMID39283962
PMCPMC12086386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.